Journals / MN Kardiyoloji / 2001 / Cilt: 8 - Sayı: 1

Results of intermittent veno-venous hemofiltration in patients with end stage heart failure resistant to high doses of diuretics

Yüksek doz diüretik tedaviye dirençli son dönem konjestif kalp yetmezlikli olgularda intermitan venö-venöz hemofiltrasyon tedavisi sonuçlarımız

Pages
48–50
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

CONCLUSION: IVVH, is a treatment alternative to obviate symptoms of peripheral and pulmonary congestion in severe heart failure patients refractory to high doses of diuretic treatment

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AIM: To evaluate potential benefits and complications of intermitent veno-venous hemofiltration (IVVH) in patients with end stage heart failure resistant to high doses of diuretics.
📊
Key Findings & Data:RESULTS: We treated 3 (2 women, 1 man) New York Heart Association (NYHA) class 4 patients with anasarca edema refractory to high doses of diuretics with IVVH.
💡
Conclusion & Impact:CONCLUSION: IVVH, is a treatment alternative to obviate symptoms of peripheral and pulmonary congestion in severe heart failure patients refractory to high doses of diuretic treatment
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Periton diyalizi · sürekli ayaktan · İlaç direnci

Abstract

AIM: To evaluate potential benefits and complications of intermitent veno-venous hemofiltration (IVVH) in patients with end stage heart failure resistant to high doses of diuretics. MATERIAL AND METHOD: We evaluated the patients charts who had been treated with IVVH. RESULTS: We treated 3 (2 women, 1 man) New York Heart Association (NYHA) class 4 patients with anasarca edema refractory to high doses of diuretics with IVVH. The patients had 8 sessions of IVVH. We could successfully remove fluid overload in a total of 148 hours at a rate of 560 cc/hour. No electrolyte imbalance appeared during the sessions. In one session we had to cease hemofiltration earlier than planned because of catheter thrombosis. Two of the patients deceased during their hospital course because of progressive heart failure. The other one was successfully switched to chronic ambulatuar peritone dialysis (CAPD) programme. Her symptom status was NYHA 3 when she was discharged. She is still alive 14 months after the CAPD programme and is under routine outpatient clinic control. CONCLUSION: IVVH, is a treatment alternative to obviate symptoms of peripheral and pulmonary congestion in severe heart failure patients refractory to high doses of diuretic treatment

Özet

AMAÇ: Yüksek doz diüretik tedaviye dirençli, volüm yükü belirgin olan, son dönem konjestif kalp yetmezlikli olgularda intermitan venö-venöz hemofiltrasyon (IVVH) tedavisinin olası yararlarını ve işleme bağlı komplikasyonların değerlendirilmesi. GEREÇ VE YÖNTEM: IVVH uygulanan hastaların dosya kayıtları retrospektif olarak gözden geçirildi. BULGULAR: Ankara Üniversitesi Kardiyoloji Kliniği'ne NYHA sınıflamasına göre 4. grup kalp yetmezliği tanısıyla yatırılan üç olguya (2 kadın,1 erkek) toplam 8 seansta yapılan 148 saat IVVH tedavisinin kayıtları dosyaların geriye dönük incelemesi sonrasında değerlendirildi. Yapılan 8 IVVH seansından birinde kateter trombozu nedeniyle işlem erken sonlandırıldı. Diğer 7 seansta başlangıçta hedeflenen miktarda sıvı dolaşımdan başarıyla çekildi. Ultrafiltrasyon hızı ortalama 560 cc/saat olan bu seanslar sonucunda hastalarda majör elektrolit imbalansına neden olunmadan anlamlı miktarda sıvı yükü dolaşımdan çekilebildi. Olgulardan ikisi IVVH seansları devam ederken kaybedildi. Halen hayatta olan tek olgu ise kronik ambulatuvar periton diyalizi (CAPD) p rogramına alınarak taburcu edildi, semptom grubu class 4'den 3'e geriledi. Bu hasta halen CAPD programında 14 . ayında poliklinik kontrolleri ile takip edilmektedir SONUÇ: IVVH, yüksek doz diüretik tedaviye dirençli son dönem konjestif kalp yetmezlikli olg ularda pulmoner konjesyon ve periferik ödemin giderilmesi amacıyla kullanılabilecek bir ultrafiltrasyon yöntemidir.

🔖

Cite This Article

SAYIN, T., KOÇUM, T., AKYÜREK, Ö., KILIÇKAP, M., ÖZENCİ, M. (2001). Results of intermittent veno-venous hemofiltration in patients with end stage heart failure resistant to high doses of diuretics. MN Kardiyoloji, Cilt: 8 - Sayı: 1, 48–50. https://ajindex.com/articles/299213

References (1)

  1. Ghali JK, Cooper R, Ford E. Trends for hospitalization for heart failure in the United States, 1973-1986: Evidence for increasing population prevalence. Arch Intern Med 1990;150:769. Wilson JR, Schwartz JD, Sutton MS, Ferrano N, Horowitz LN, Reichek N, Josephson ME. Prognosis in severe heart failure:Relation to hemodynamic measurements and ventricular ectopic activity. J Am Coll Cardiol 1983;2:403. Brophy JM, Deslauriers G, Rouleau JL. Long term prognosis of patients presenting to the emergency room with decompansated congestive heart failure. Can J Cardiol 1994;1:543. Garg R, Yusuf S. Overview of randomized trials of angiotensin converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA 1995;273:1450. Ragazzoni E, Sacco A, Cusinato S et al. Heart failure resistant to drug therapy. Nephrologic approach. Minerva Urol Nefrol 1998;50:133. Schrier RW.Abdallah JG.Weinberger HD, Abraham WT. Therapy of heart failure. Kidney International 2000;57:1418. Mann H, Konigs F, Heintz P, et al. Vasoactive hormones during hemodialysis with intermittent ultrafiltration. ASAIO Trans 1990;36:M367-9. Agostoni P, Marenzi G, Lauri G et al. Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency. Failure of Furosemide to provide the same result. Am J Med 1994;96:191.